Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome

Audrey Graham, Isobel Ford, Rona Morrison, Robert N. Barker, Mike Greaves, Lars Peter Erwig

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Antiphospholipid syndrome is an important cause of recurrent thrombotic events. The pathogenesis of the thrombosis remains unclear, but it has been suggested that anti-phospholipid Abs, which are laboratory markers for the disease and include species capable of binding to vascular endothelial cells, play an important role. We hypothesized that these anti-endothelial Abs promote thrombosis through interference with clearance of dying cells. We show that healthy endothelial cell monolayers effectively remove apoptotic endothelial cells, but this clearance is markedly inhibited by serum or IgG from patients with antiphospholipid syndrome and anti-endothelial Abs. In addition, patient sera or IgG opsonize apoptotic endothelial cells and cause enhanced Fc-mediated uptake by professional phagocytes. Importantly, the delayed clearance of apoptotic cells by healthy endothelial cells and the enhanced Fc-mediated macrophage uptake each result in procoagulant consequences, as judged by increased thrombin generation. The effects on apoptotic cell clearance were reproduced by a mAb derived from a patient with antiphospholipid syndrome, which binds to endothelial cells and is thrombogenic in experimental models. Taken together, our data support a novel, dual mechanism by which anti-endothelial Abs are prothrombotic in antiphospholipid syndrome by inhibiting removal of procoagulant apoptotic cells and by diverting their clearance to provoke inflammatory and prothrombotic changes in professional phagocytes.
Original languageEnglish
Pages (from-to)1756-1762
Number of pages7
JournalThe Journal of Immunology
Volume182
Issue number3
Publication statusPublished - 1 Feb 2009

Fingerprint

Antiphospholipid Syndrome
Anti-Idiotypic Antibodies
Thrombosis
Endothelial Cells
Phagocytes
Immunoglobulin G
Serum
Thrombin
Phospholipids
Theoretical Models
Biomarkers
Macrophages

Keywords

  • animals
  • antibodies, antiphospholipid
  • antiphospholipid syndrome
  • apoptosis
  • binding sites, antibody
  • blood coagulation factors
  • cell line
  • cell movement
  • endothelium, vascular
  • humans
  • hybridomas
  • macrophages
  • mice
  • opsonin proteins
  • phagocytosis
  • thrombosis
  • time Factors
  • platelets
  • enothelial cells

Cite this

Graham, A., Ford, I., Morrison, R., Barker, R. N., Greaves, M., & Erwig, L. P. (2009). Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. The Journal of Immunology, 182(3), 1756-1762.

Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. / Graham, Audrey; Ford, Isobel; Morrison, Rona; Barker, Robert N. ; Greaves, Mike; Erwig, Lars Peter.

In: The Journal of Immunology, Vol. 182, No. 3, 01.02.2009, p. 1756-1762.

Research output: Contribution to journalArticle

Graham, A, Ford, I, Morrison, R, Barker, RN, Greaves, M & Erwig, LP 2009, 'Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome', The Journal of Immunology, vol. 182, no. 3, pp. 1756-1762.
Graham, Audrey ; Ford, Isobel ; Morrison, Rona ; Barker, Robert N. ; Greaves, Mike ; Erwig, Lars Peter. / Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. In: The Journal of Immunology. 2009 ; Vol. 182, No. 3. pp. 1756-1762.
@article{6497d00bd75c4a538b0018146507bd02,
title = "Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome",
abstract = "Antiphospholipid syndrome is an important cause of recurrent thrombotic events. The pathogenesis of the thrombosis remains unclear, but it has been suggested that anti-phospholipid Abs, which are laboratory markers for the disease and include species capable of binding to vascular endothelial cells, play an important role. We hypothesized that these anti-endothelial Abs promote thrombosis through interference with clearance of dying cells. We show that healthy endothelial cell monolayers effectively remove apoptotic endothelial cells, but this clearance is markedly inhibited by serum or IgG from patients with antiphospholipid syndrome and anti-endothelial Abs. In addition, patient sera or IgG opsonize apoptotic endothelial cells and cause enhanced Fc-mediated uptake by professional phagocytes. Importantly, the delayed clearance of apoptotic cells by healthy endothelial cells and the enhanced Fc-mediated macrophage uptake each result in procoagulant consequences, as judged by increased thrombin generation. The effects on apoptotic cell clearance were reproduced by a mAb derived from a patient with antiphospholipid syndrome, which binds to endothelial cells and is thrombogenic in experimental models. Taken together, our data support a novel, dual mechanism by which anti-endothelial Abs are prothrombotic in antiphospholipid syndrome by inhibiting removal of procoagulant apoptotic cells and by diverting their clearance to provoke inflammatory and prothrombotic changes in professional phagocytes.",
keywords = "animals, antibodies, antiphospholipid, antiphospholipid syndrome, apoptosis, binding sites, antibody, blood coagulation factors, cell line, cell movement, endothelium, vascular, humans, hybridomas, macrophages, mice, opsonin proteins, phagocytosis, thrombosis, time Factors, platelets, enothelial cells",
author = "Audrey Graham and Isobel Ford and Rona Morrison and Barker, {Robert N.} and Mike Greaves and Erwig, {Lars Peter}",
year = "2009",
month = "2",
day = "1",
language = "English",
volume = "182",
pages = "1756--1762",
journal = "The Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome

AU - Graham, Audrey

AU - Ford, Isobel

AU - Morrison, Rona

AU - Barker, Robert N.

AU - Greaves, Mike

AU - Erwig, Lars Peter

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Antiphospholipid syndrome is an important cause of recurrent thrombotic events. The pathogenesis of the thrombosis remains unclear, but it has been suggested that anti-phospholipid Abs, which are laboratory markers for the disease and include species capable of binding to vascular endothelial cells, play an important role. We hypothesized that these anti-endothelial Abs promote thrombosis through interference with clearance of dying cells. We show that healthy endothelial cell monolayers effectively remove apoptotic endothelial cells, but this clearance is markedly inhibited by serum or IgG from patients with antiphospholipid syndrome and anti-endothelial Abs. In addition, patient sera or IgG opsonize apoptotic endothelial cells and cause enhanced Fc-mediated uptake by professional phagocytes. Importantly, the delayed clearance of apoptotic cells by healthy endothelial cells and the enhanced Fc-mediated macrophage uptake each result in procoagulant consequences, as judged by increased thrombin generation. The effects on apoptotic cell clearance were reproduced by a mAb derived from a patient with antiphospholipid syndrome, which binds to endothelial cells and is thrombogenic in experimental models. Taken together, our data support a novel, dual mechanism by which anti-endothelial Abs are prothrombotic in antiphospholipid syndrome by inhibiting removal of procoagulant apoptotic cells and by diverting their clearance to provoke inflammatory and prothrombotic changes in professional phagocytes.

AB - Antiphospholipid syndrome is an important cause of recurrent thrombotic events. The pathogenesis of the thrombosis remains unclear, but it has been suggested that anti-phospholipid Abs, which are laboratory markers for the disease and include species capable of binding to vascular endothelial cells, play an important role. We hypothesized that these anti-endothelial Abs promote thrombosis through interference with clearance of dying cells. We show that healthy endothelial cell monolayers effectively remove apoptotic endothelial cells, but this clearance is markedly inhibited by serum or IgG from patients with antiphospholipid syndrome and anti-endothelial Abs. In addition, patient sera or IgG opsonize apoptotic endothelial cells and cause enhanced Fc-mediated uptake by professional phagocytes. Importantly, the delayed clearance of apoptotic cells by healthy endothelial cells and the enhanced Fc-mediated macrophage uptake each result in procoagulant consequences, as judged by increased thrombin generation. The effects on apoptotic cell clearance were reproduced by a mAb derived from a patient with antiphospholipid syndrome, which binds to endothelial cells and is thrombogenic in experimental models. Taken together, our data support a novel, dual mechanism by which anti-endothelial Abs are prothrombotic in antiphospholipid syndrome by inhibiting removal of procoagulant apoptotic cells and by diverting their clearance to provoke inflammatory and prothrombotic changes in professional phagocytes.

KW - animals

KW - antibodies, antiphospholipid

KW - antiphospholipid syndrome

KW - apoptosis

KW - binding sites, antibody

KW - blood coagulation factors

KW - cell line

KW - cell movement

KW - endothelium, vascular

KW - humans

KW - hybridomas

KW - macrophages

KW - mice

KW - opsonin proteins

KW - phagocytosis

KW - thrombosis

KW - time Factors

KW - platelets

KW - enothelial cells

M3 - Article

VL - 182

SP - 1756

EP - 1762

JO - The Journal of Immunology

JF - The Journal of Immunology

SN - 0022-1767

IS - 3

ER -